Immunosuppressive agent that inhibits de novo purine nucleotide synthesis via inhibition of inosine-5’-monophosphate (IMP). Prevents the formation of xanthosine-5’-monophosphate (XMP) and guanosine-5’-monophosphate (GMP). Depletes tetrahydrobiopterin and decreases nitric oxide (NO) production by iNOS (NOS II) without affecting nNOS (NOS I) activity. Suppresses cytokine-induced nitric oxide (NO) production in mouse and rat vascular endothelial cells.
Ansamycin. Displays antibacterial and antifungal activity.